# Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)

> **NCT06852924** · NA · RECRUITING · sponsor: **Novlead Inc.** · enrollment: 100 (estimated)

## Conditions studied

- High Altitude Pulmonary Hypertension

## Interventions

- **DEVICE:** Nitric Oxide Generation and Delivery System

## Key facts

- **NCT ID:** NCT06852924
- **Lead sponsor:** Novlead Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06852924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06852924, "Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06852924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*